US FDA Hiring Strategy Shifts Focus From ‘Vacancies’ To ‘Net Gains’
As outside report urges increased planning and culture changes, FDA OTS Director Keller says recruitment will stop ‘order taking’ and move to ‘forecasting the hiring needs of each of the centers.’
You may also be interested in...
The $500m in additional funds would support pandemic-related activities, potentially for additional staff or technology upgrades.
Other subgroups negotiating specific issues for the user fee reauthorization have indicated that agreements are close.
'Indirect and direct review roles' would be added with user fee funds after the PDUFA program is reauthorized.